Elevance Health management check

ELV · Health Care · Managed Health Care · CEO Gail Boudreaux

Filings as of

75
Management score, ranked 114th of 487 · 12th of 60 in Health Care5 good · 1 to watch · 1 flaggedStrongest: stable leadership · Weakest: owner returns · Best and worst run in Health Care →

Closest peers in Managed Health Care

  1. 108MTDMettler Toledo76
  2. 111AMGNAmgen76
  3. 114ELVElevance Health75
  4. 357HUMHumana57
  5. 447CNCCentene Corporation47
  6. 460UNHUnitedHealth Group42

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$117Peers$148

    What $100 became since fiscal 2021

    2431st
    Detail

    $100 invested at the start of fiscal 2021 grew to $117, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8043rd
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.59 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.4% of net income

    $22.6m pay · $5.7bn net income, FY2025

    0.1%1%3%10%
    8382nd
    Detail

    $22.6m of reported pay in fiscal 2025, against $5.7bn of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 2.8 years of pay

    171,976 shares ≈ $63.3m

    0.1y1y5y20y100y

    6 mo: ▲ $1.4m bought · ▼ $5.4m sold

    5763rd
    Detail

    The CEO holds 171,976 shares, directly or through trusts (unvested awards not counted): about 2.8 years of pay. Both: 2 buyers ($1.4m) and 4 sellers ($5.4m) in six months.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 247m2025 · 225m

    Diluted shares −2.7% a year; flagged above +2%

    0%10%20%

    Stock pay 0.1% of revenue

    8476th
    Detail

    Diluted shares changed -2.7% a year over the last three fiscal years. Stock-based pay was 0.1% of revenue in the latest year.

  • Good

    Is leadership stable?

    3 leadership filings in 3 years

    3 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Gail Boudreaux

    100100th
    Detail

    CEO in the pay table: Gail Boudreaux. 3 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 27, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$4.0m$23.2m$50.4m$10020212022202320242025$117$148

Pay tied most to Adjusted Shareholders' Net Income

Other key measuresOperating RevenueAdjusted Shareholders' Net Income GrowthTotal Revenue GrowthAdjusted EPS

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Gail Boudreaux$22.6m$18.8m$7.2m$117$148$5.7bn
2024—$20.5m−$4.0m$6.3m$121$129$6.0bn
2023—$21.9m$16.2m$8.9m$152$126$6.0bn
2022—$20.9m$35.3m$6.7m$163$124$5.9bn
2021—$19.3m$50.4m$6.4m$146$126$6.1bn

Insiders and the CEO's stakeMixed

President and CEO
Gail Boudreaux
Shares held
171,976
At that filing's price
≈ $63.3m
Latest Form 4
Jul 17, 2026

Both: 2 buyers ($1.4m) and 4 sellers ($5.4m) in six months.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtGail BoudreauxPresident and CEO$1.0mJul 17, 2026
  • BoughtRamiro G PeruDirector$366kJul 17, 2026
  • SoldMark KayeEVP & CFO$4.7mOct 22, 2026
  • SoldRatnakar LavuEVP & Chief Digital Info Ofr$572kNov 5, 2026

Leadership and governance on file

20222023202420252026Leadership 6Votes 5
All 6 filings

Latest shareholder vote results: May 13, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $19.2bn returned to owners in buybacks and dividends, 65% of net income, and $1.3bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$3.1bn$6.2bn20212022202320242025Shares247m243m237m233m225m
Show the figures
Fiscal year20212022202320242025
Revenue$138.6bn$156.6bn$171.3bn$177.0bn$199.1bn
Net income$6.2bn$5.9bn$6.0bn$6.0bn$5.7bn
Stock-based pay$255.0m$264.0m$289.0m$191.0m$276.0m
Buybacks$1.9bn$2.3bn$2.7bn$2.9bn$2.6bn
Dividends$1.1bn$1.2bn$1.4bn$1.5bn$1.5bn
Diluted shares247m243m237m233m225m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.